Identification of men at lower risk of prostate cancer by PRS stratification has been shown to be useful in reducing overdiagnosis in the general population, resulting in a reduction in the harms associated with prostate-specific antigen testing (42). The gene discussed is KLK3; the disease is prostate carcinoma.